Table 2 Distribution of study covariates and hospital outcomes of WOMEN with and without T2DM with infective endocarditis in Spain (2016–2020), before and after propensity score matching (PSM)
Before PSM | After PSM | |||||
|---|---|---|---|---|---|---|
T2DM | No T2DM | p-value | T2DM | No T2DM | p-value | |
N, (incidence per 100,000 women per year) | 839 (11.91) | 2469 (4.01) | < 0.001 | 839 | 839 | NA |
Age, mean (SD) | 75.58 (9) | 73.13 (12.57) | < 0.001 | 75.58 (9) | 76.81 (10.12) | 0.008 |
40–66 years old, n (%) | 122 (14.54) | 678 (27.46) | < 0.001 | 122 (14.54) | 122 (14.54) | 0.008 |
67–75 years old, n (%) | 264 (31.47) | 568 (23.01) | 264 (31.47) | 209 (24.91) | ||
≥ 76 years old, n (%) | 453 (53.99) | 1223 (49.53) | 453 (53.99) | 508 (60.55) | ||
Acute renal disease, n (%) | 205 (24.43) | 489 (19.81) | 0.004 | 205 (24.43) | 200 (23.84) | 0.775 |
Chronic renal disease, n (%) | 257 (30.63) | 394 (15.96) | < 0.001 | 257 (30.63) | 244 (29.08) | 0.488 |
Congestive heart failure, n (%) | 146 (17.4) | 254 (10.29) | < 0.001 | 146 (17.4) | 129 (15.38) | 0.262 |
COPD, n (%) | 35 (4.17) | 74 (3) | 0.100 | 35 (4.17) | 37 (4.41) | 0.810 |
Dementia, n (%) | 34 (4.05) | 60 (2.43) | 0.015 | 34 (4.05) | 31 (3.69) | 0.704 |
Atrial fibrillation, n (%) | 319 (38.02) | 872 (35.32) | 0.159 | 319 (38.02) | 308 (36.71) | 0.579 |
COVID-19, n (%) | 6 (0.72) | 13 (0.53) | 0.532 | 6 (0.72) | 6 (0.72) | 0.999 |
Ischemic heart disease, n (%) | 114 (13.59) | 229 (9.28) | < 0.001 | 114 (13.59) | 110 (13.11) | 0.774 |
Previous aortic valve disease, n (%) | 206 (24.55) | 633 (25.64) | 0.533 | 206 (24.55) | 196 (23.36) | 0.567 |
Previous mitral valve disease, n (%) | 268 (31.94) | 788 (31.92) | 0.988 | 268 (31.94) | 263 (31.35) | 0.793 |
Previous pulmonic valve disease, n (%) | 2 (0.24) | 6 (0.24) | 0.981 | 2 (0.24) | 1 (0.12) | 0.563 |
Previous tricuspid valve disease, n (%) | 94 (11.2) | 233 (9.44) | 0.139 | 94 (11.2) | 97 (11.56) | 0.818 |
Prosthetic valve carriers, n (%) | 83 (9.89) | 241 (9.76) | 0.912 | 83 (9.89) | 87 (10.37) | 0.746 |
CCI index, mean (SD) | 1.41 (0.99) | 1.13 (1) | < 0.001 | 1.41 (0.99) | 1.32 (1.07) | 0.097 |
Periannular complications / atrioventricular block, n (%) | 45 (5.36) | 93 (3.77) | 0.046 | 45 (5.36) | 32 (3.81) | 0.129 |
Septic arterial embolism, n (%) | 35 (4.17) | 103 (4.17) | 0.999 | 35 (4.17) | 23 (2.74) | 0.109 |
Cardiogenic shock, n (%) | 14 (1.67) | 52 (2.11) | 0.434 | 14 (1.67) | 16 (1.91) | 0.713 |
Dialysis, n (%) | 64 (7.63) | 105 (4.25) | < 0.001 | 64 (7.63) | 33 (3.93) | 0.001 |
Heart valve surgery (aortic, mitral, tricuspid, pulmonary), n (%) | 121 (14.42) | 414 (16.77) | 0.111 | 121 (14.42) | 108 (12.87) | 0.355 |
Mechanical ventilation, n (%) | 87 (10.37) | 254 (10.29) | 0.946 | 87 (10.37) | 74 (8.82) | 0.281 |
Pacemaker implantation, n (%) | 41 (4.89) | 97 (3.93) | 0.231 | 41 (4.89) | 32 (3.81) | 0.290 |
LOHS, Median (IQR) | 18 (25) | 18 (26) | 0.778 | 18 (25) | 18 (26) | 0.823 |
IHM, n (%) | 190 (22.65) | 498 (20.17) | 0.127 | 190 (22.65) | 187 (22.29) | 0.861 |